Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • DRUGS AND BIOLOGICS—D.S.D.: 340B contract pharmacy delivery protections not preempted, avoid constitutional limits
    • ANTITRUST—9th Cir.: Stipulated judgment entered on faulty jury instruction reversed because Kodak/Epic factors were inapplicable
    • ANTITRUST—E.D. Pa.: Generic drug makers largely fail to exclude Humana damages expert opinion
    • CONTROLLED SUBSTANCES—FINAL RULES: DEA places O-DSMT in schedule I
    • DRUGS AND BIOLOGICS—FDA GUIDANCE NOTICES: Container Closure Systems for Human Drugs and Biological Products; Draft Guidance for Industry; Availability
    • FOOD SAFETY—Mo. App.: New trial affirmed for minor sickened by preterm baby formula
    • LABELING AND PACKAGING (FOOD, DRUGS & MEDICAL DEVICES)—S.D.N.Y.: Case against maker of Enfamil infant formula moves forward
    • REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments
    • WORTH NOTING—Other Health Law litigation and regulatory developments
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—FINAL RULES: DEA places O-DSMT in schedule I, (Aug 17, 2026)

    By WK Editorial Staff

    The DEA issued a temporary order to schedule O-desmethyltramadol, including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act.

    The Drug Enforcement Administration (DEA) bases th ...

    By WK Editorial Staff

    The DEA issued a temporary order to schedule O-desmethyltramadol, including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act.

    The Drug Enforcement Administration (DEA) bases this action on a finding that placing O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol) in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle O-DSMT (Final Rule, 91 Fed. Reg. 52013 (Aug. 12, 2026)).

    Dates. The temporary order is effective August 12, 2026, until August 12, 2028.

    FederalRegisterIssuances: FinalRules ControlledNews GeneralNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use